Transcode therapeutics stock.

Transcode Therapeutics Inc RNAZ shares are trading lower by 69% to $0.79 Tuesday morning after the company priced its $8 million public offering of 15.7 million shares at $0.51 per share.

Transcode therapeutics stock. Things To Know About Transcode therapeutics stock.

8 thg 7, 2021 ... The shares are expected to begin trading on the Nasdaq Capital Market on July 9, 2021 under the symbol “RNAZ.” The offering is expected to close ...TransCode Therapeutics Announces Closing of $8.5 Million Public Offering finance.yahoo.com - September 28 at 6:53 PM: Why Transcode Therapeutics (RNAZ) Stock Is Down Nearly 70% benzinga.com - September 26 at 2:06 PM: Transcode Therapeutics stock whipsaws lower after cut price placing proactiveinvestors.com - …Sep 25, 2023 · By Ben Glickman. Shares of TransCode Therapeutics jumped Monday after reporting positive study results for its lead cancer treatment candidate. The stock was up 96% at $1.30 in morning trading. Dec 1, 2023 · The Investor Relations website contains information about TransCode Therapeutics's business for stockholders, potential investors, and financial analysts. 28 thg 9, 2023 ... BOSTON, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to ...

Stock Price Forecast The 1 analysts offering 12-month price forecasts for Transcode Therapeutics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00.

UNITED STATES . SECURITIES AND EXCHANGE COMMISSION . Washington, D.C. 20549 FORM 8-K. CURRENT REPORT . Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

4 ngày trước ... 30, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively ...Dec 4, 2023 · BOSTON, Dec. 04, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA ... TransCode Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $12.00. See the top stocks recommended by analysts >> Tarsus Pharmaceuticals (TARS)The Trade: TransCode Therapeutics, Inc. RNAZ CEO Michael Robert Dudley acquired a total 18,607 shares an average price of $2.62. To acquire these shares, it cost around $48.66 thousand.TransCode is an RNA oncology company created on the belief that cancer can be more effectively treated using RNA therapeutics. The Company has created a platform of drug candidates designed to ...

BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA ...

Overview News TransCode Therapeutics Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-19.57 Market Cap $4.82 M Shares …

TransCode Therapeutics (NASDAQ: RNAZ) stock is rallying higher on Wednesday after the company withdrew plans for a secondary offering. According to the company, it won’t pursue a plan to sell 12 ...TransCode Therapeutics, Inc. 0.3599. +0.0338. +10.36%. BOSTON, Oct. 30, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (the “Company”), the RNA oncology company committed ...If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...TransCode Therapeutics ( NASDAQ: RNAZ) Thursday announced the commencement of an underwritten public offering of shares of its common stock. In addition, the company said it expects to grant the ...TransCode Therapeutics (NASDAQ: RNAZ) stock is rocketing higher on Wednesday after the company withdrew a stock offering.. This comes from a filing with the U.S. Securities and Exchange Commission ...TransCode Therapeutics, Inc. | 1,311 followers on LinkedIn. Delivering a cancer-free future. | TransCode's lofty goal is delivering a cancer-free future for all cancer patients. …PTC Therapeutics (NASDAQ: PTCT) stock is falling on Friday after the biopharmaceutical company released its earnings report for the third quarter of 2023. The bad news for PTCT stock starts with ...

TSLA Tesla, Inc. Common Stock $230.05 +0.01 BETR Better Home & Finance Holding Company Class A Common Stock $1.56 +0.41 +35.65% Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the...WATERTOWN, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced that it has commenced an underwritten public offering of $175 million of …TransCode Therapeutics (NASDAQ: RNAZ) stock is rocketing higher on Wednesday after the company withdrew a stock offering.. This comes from a filing with the U.S. Securities and Exchange Commission ...TransCode Therapeutics (NASDAQ:RNAZ) stock is taking a beating on Friday after the oncology company announced plans for a public share offering.Oct 27, 2023 · BOSTON, Oct. 27, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA ... Stock analysis for TransCode Therapeutics Inc (RNAZ:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

According to a press release, TransCode Therapeutics is offering 15.7 million shares of RNAZ stock for 51 cents each. This has the company expecting to raise $8 million in gross proceeds from the ...

Sep 25, 2023 · AboutTransCodeTherapeutics. TransCode is an RNA oncology company created on the belief that cancer can be more effectively treated using RNA therapeutics. The Company has created a platform of ... If you are looking for stocks with good return, Transcode Therapeutics Inc stock can be a bad, high-risk 1-year investment option. Transcode Therapeutics Inc real time quote is equal to 0.240 USD at 2023-11-26, but your current investment may be devalued in …With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.About TransCode Therapeutics TransCode is an RNA oncology company created on the belief that cancer can be more effectively treated using RNA therapeutics. Using its iron oxide nanoparticle delivery platform, the Company has created a portfolio of drug candidates designed to target a variety of tumor types with the objective of …BOSTON, Dec. 04, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has closed its previously announced registered direct offering for the purchase and sale of 5,000,000 shares of common stock at a purchase price of $0.242 per share of ...Oct 26, 2023 · TransCode Therapeutics Announces Public Offering of Common Stock. October 26, 2023. PDF Version. BOSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the commencement of an ... TransCode Therapeutics Announces $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules Read full article TransCode Therapeutics, Inc.

If you are looking for stocks with good return, Transcode Therapeutics Inc stock can be a bad, high-risk 1-year investment option. Transcode Therapeutics Inc real time quote is equal to 0.240 USD at 2023-11-26, but your current investment may be devalued in …

Oct 24, 2023 · Evidence of Drug Accumulation in Metastatic Lesions. BOSTON, Oct. 24, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced preliminary results with its lead therapeutic candidate, TTX-MC138, in the first patient enrolled in its Phase 0 clinical trial aimed at ...

BOSTON, Oct. 30, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (the “Company”), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that it is withdrawing the underwritten public offering of its common stock. This reflects the Company’s belief …Therapeutic counseling is a psychological service that focuses on helping individuals learn skills and techniques to facilitate coping make improvements in their own lives. Therapeutic counseling ultimately seeks to show clients how their t...Find the latest historical data for TransCode Therapeutics, Inc. Common Stock (RNAZ) at Nasdaq.com.Price Target. Only one analyst offered a short-term price target of $3.00 for TransCode Therapeutics Inc. This represents an increase of 1% from the last closing price of $0.24.BOSTON, Dec. 04, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company …The 1-for-20 reverse stock split will automatically convert 20 current shares of TransCode’s common stock into one new share of common stock. No fractional shares will be issued in connection ...BOSTON, Dec. 04, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. RNAZ (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has closed its previously announced registered direct offering for the purchase and sale of 5,000,000 shares of common …Dec 1, 2023 · The Investor Relations website contains information about TransCode Therapeutics's business for stockholders, potential investors, and financial analysts. Transcode Therapeutics Inc stock performance at a glance. Check Transcode Therapeutics Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.

According to the U.S. Food and Drug Administration (FDA), a drug with a narrow therapeutic range (NTI) is one with a narrow range between the drug’s risks and its benefits. The NTI is also known a narrow therapeutic index or critical dose d...A few examples include what has shares of Roblox (NYSE:RBLX), PTC Therapeutics (NASDAQ:PTCT) and TransCode Therapeutics (NASDAQ:RNAZ) stock moving today. You can catch up on all of this news at ...Price Target. Only one analyst offered a short-term price target of $3.00 for TransCode Therapeutics Inc. This represents an increase of 1% from the last closing price of $0.24.Instagram:https://instagram. 1976 bicentennial quarter worthsandp 500 energy sectorgood paper trading platformbest time of day to sell stocks Nov 30, 2023 · BOSTON, Nov. 30, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has entered into a definitive securities purchase agreement for the purchase and sale of 5,000,000 shares of common stock ... citizens wealth managementtastyworks fees 26 thg 9, 2023 ... Use of technology ... TransCode Therapeutics (NASDAQ:RNAZ) stock has seen a wild 24 hours of trading as the Boston headquartered nano-cap drug ...Sep 26, 2023 · TransCode Therapeutics, Inc. BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively ... the best day trading platform TransCode Therapeutics ( NASDAQ: RNAZ) said that it has entered into a definitive securities purchase agreement for the purchase and sale of 5,000,000 shares of common stock at a purchase price of ...2,091.70 +34.50(+1.68%) TransCode Therapeutics, Inc. (RNAZ) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 0.2190 -0.0270 (-10.98%) At close: 04:00PM EST 0.2210 +0.00...